Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Jun 2019. Module: SNOMED CT United Kingdom clinical extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1623991000000118 | ALK (anaplastic lymphoma kinase) negative ALCL (anaplastic large cell lymphoma) including primary cutaneous subtypes tumour and germline WGS (whole genome sequencing) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom clinical extension module |
| 1624001000000111 | Tumour and germline whole genome sequencing for anaplastic lymphoma kinase negative anaplastic large cell lymphoma including primary cutaneous subtypes (procedure) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT United Kingdom clinical extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| ALK (anaplastic lymphoma kinase) negative ALCL (anaplastic large cell lymphoma) including primary cutaneous subtypes tumour and germline WGS (whole genome sequencing) | Method | Evaluation - action | false | Inferred relationship | Existential restriction modifier | ||
| ALK (anaplastic lymphoma kinase) negative ALCL (anaplastic large cell lymphoma) including primary cutaneous subtypes tumour and germline WGS (whole genome sequencing) | Is a | Tumour and germline whole genome sequencing (procedure) | true | Inferred relationship | Existential restriction modifier | ||
| ALK (anaplastic lymphoma kinase) negative ALCL (anaplastic large cell lymphoma) including primary cutaneous subtypes tumour and germline WGS (whole genome sequencing) | Method | Evaluation - action | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR